| Financial Year |
September 30 2021 |
| Monetary Funds |
11,048,372.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
110,510,582.76 |
| Advances to Suppliers |
5,996,618.10 |
| Other Receivables |
11,968,859.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
53,412,479.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
260,111.51 |
| Total Current Assets |
193,197,024.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,794,490.40 |
| Investment Properties |
-- |
| Fixed Assetes |
18,988,755.74 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,145,502.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
43,533.56 |
| Deferred Income Tax Assets |
100,831,262.73 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
129,803,544.53 |
| Total Assets |
323,000,569.19 |
| Short-Term Loans |
2,594,773.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
239,283,597.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,057,043.44 |
| Taxes Payable |
433,654.63 |
| Interest Payable |
19,608,094.58 |
| Dividend Payable |
-- |
| Other payables |
97,754,160.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
94,617,108.97 |
| Other Current Liabilities |
1,682,174.41 |
| Sub-Total of Current Liabilities |
469,422,513.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
112,821,173.46 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,831,173.46 |
| Total Liabilities |
584,253,686.67 |
| Paid-In Capital(Or Share Stock) |
320,040,000.00 |
| Capital Surplus |
334,113,722.57 |
| Surplus Reserve |
24,261,522.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-954,092,346.12 |
| Minority Stockholder's Interest |
14,423,983.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-275,677,100.68 |
| Owner's Equity（Stockholder's Equity） |
-261,253,117.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
323,000,569.19 |
